Form 4: Merit Medical CFO Raul Parra Jr. Exercises Options and Sells Shares
SEC Form 4
Raul Parra Jr., CFO and Treasurer of Merit Medical Systems, exercised stock options and sold shares on November 7, 2024.
Summary
- On November 7, 2024, Raul Parra Jr., CFO and Treasurer of Merit Medical Systems Inc., exercised non-qualified stock options to acquire 5,361 shares of common stock at a price of $37.71 per share.
- Simultaneously, Parra sold 5,361 shares of common stock at a weighted average price of $102.18, with individual transactions ranging from $102.17 to $102.25.
- Following these transactions, Parra directly owns 16,361 shares of Merit Medical Systems Inc.
- Parra also indirectly owns 2,770 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: This is a neutral event. The CFO exercised options and sold shares, which is a common practice. The sale price was significantly higher than the exercise price, indicating a profit for the CFO.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The exercise and sale of shares by executives are common occurrences and are generally viewed in the context of their overall compensation and investment strategies.
- Comparable companies in the medical device industry, such as Medtronic or Boston Scientific, also have executives who regularly file Form 4s related to stock option exercises and share sales.
Stakeholder Impact
- The transaction could have a minor impact on shareholders, depending on their interpretation of the insider's actions.
- The sale of shares by the CFO could be perceived as a lack of confidence in the company's future performance, although it could also be a routine part of personal financial planning.
Key Dates
| Date | Description |
|---|---|
| 02/26/2021 | Date from which non-qualified stock options become exercisable in equal annual installments of 25%. |
| 03/19/2022 | Date from which non-qualified stock options become exercisable in equal annual installments of 25%. |
| 02/28/2023 | Date from which non-qualified stock options become exercisable in equal annual installments of 25%. |
| 02/28/2024 | Date from which non-qualified stock options become exercisable in equal annual installments of 25%. |
| 11/07/2024 | Date of the transaction: exercise of stock options and sale of shares. |
| 11/11/2024 | Date of signature on the Form 4 filing. |
| 02/26/2027 | Expiration date of non-qualified stock options. |
| 03/19/2028 | Expiration date of non-qualified stock options. |
| 02/28/2029 | Expiration date of non-qualified stock options. |
| 02/28/2030 | Expiration date of non-qualified stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.